Fluorodeoxyglucose positron emission tomography (FDG/PET) shows the effect of carbon-ion radiotherapy (CIRT); with pathologic confirmation.

CT guided biopsy Carbon-ion radiotherapy(CIRT) FDG-PET Metastasis Pleomorphic liposarcoma

Journal

Radiology case reports
ISSN: 1930-0433
Titre abrégé: Radiol Case Rep
Pays: Netherlands
ID NLM: 101467888

Informations de publication

Date de publication:
May 2023
Historique:
received: 30 12 2022
revised: 30 01 2023
accepted: 01 02 2023
entrez: 14 3 2023
pubmed: 15 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

Response evaluation of carbon-ion radiotherapy poses a diagnostic challenge. Due to its functional aspects, fluorodeoxyglucose positron emission tomography (FDG/PET) has a role in the diagnosis of photon radiation therapy. In addition, several studies suggested that FDG/PET may be useful to select the optimal site for performing a diagnostic biopsy. Here, we report a 73-year-old female in which FDG/PET was effective in determining the recurrence of liposarcoma and the therapeutic effect. Based on the results of FDG/PET, we could make a pathologic definitive diagnosis and selectively performing carbon-ion radiotherapy for active tumors.

Identifiants

pubmed: 36915607
doi: 10.1016/j.radcr.2023.02.007
pii: S1930-0433(23)00111-5
pmc: PMC10006709
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1793-1795

Informations de copyright

© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Références

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):828-33
pubmed: 18374507
In Vivo. 2019 Mar-Apr;33(2):529-533
pubmed: 30804137
Front Oncol. 2020 Feb 04;10:82
pubmed: 32117737
J Int Med Res. 2021 Apr;49(4):3000605211009701
pubmed: 33884917
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):256-263
pubmed: 30504319
Int J Part Ther. 2021 Jun 25;8(1):131-154
pubmed: 34285942
Blood. 2014 May 1;123(18):2749-50
pubmed: 24786452

Auteurs

Jun Aoki (J)

Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Yayoi Yamamoto (Y)

Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Ayumi Horikawa (A)

Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Tsunehiro Doiuchi (T)

Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Ayako Hino (A)

Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Daichi Kojima (D)

Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Hiroaki Kurihara (H)

Department of Radiology and Interventional Radiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Kota Washimi (K)

Department of Pathology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Hiroyuki Katoh (H)

Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Toru Hiruma (T)

Department of Musculoskeletal Tumor Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Classifications MeSH